{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:42:21Z","timestamp":1768642941625,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.purol.2022.04.011","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T08:10:34Z","timestamp":1655885434000},"page":"672-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?"],"prefix":"10.1016","volume":"32","author":[{"given":"X.","family":"Gam\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-N.","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ph\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Perrouin-Verbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Aublant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chartier-Kastler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.purol.2022.04.011_bib0130","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/nau.23551","article-title":"6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and treatment or urinary incontinence, pelvic organ prolapse and faecal incontinence","volume":"37","author":"Abrams","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.purol.2022.04.011_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/DCR.0b013e3181f46810","article-title":"Patient experience and satisfaction with sacral neuromodulation: results of a single-center sample survey","volume":"54","author":"van Wunnik","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20330","article-title":"In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction","volume":"26","author":"Foster","year":"2007","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.juro.2010.09.090","article-title":"Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey","volume":"185","author":"Leong","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12325-019-01205-z","article-title":"New technologies and applications in sacral neuromodulation: an update","volume":"37","author":"De Wachter","year":"2020","journal-title":"Adv Ther"},{"issue":"S2","key":"10.1016\/j.purol.2022.04.011_bib0155","first-page":"S9","article-title":"Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder","volume":"37","author":"Blok","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0160","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/nau.23892","article-title":"A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study","volume":"38","author":"Blok","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0165","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/nau.24615","article-title":"Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system","volume":"40","author":"Pezzella","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.purol.2022.04.011_bib0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000488684","article-title":"Battery longevity comparison of two commonly available dual channel implantable pulse generators used for subthalamic nucleus stimulation in Parkinson's disease","volume":"96","author":"Fisher","year":"2018","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.purol.2022.04.011_bib0175","series-title":"[ACTIVA RC, dual channel rechargeable system for deep brain stimulation (DBS)]","author":"CNEDiMTS","year":"2020"},{"issue":"3","key":"10.1016\/j.purol.2022.04.011_bib0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3171\/2018.4.JNS172995","article-title":"Reduced long-term cost and increased patient satisfaction with rechargeable implantable pulse generators for deep brain stimulation","volume":"131","author":"Hitti","year":"2018","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.purol.2022.04.011_bib0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ner.12748","article-title":"Rechargeable internal pulse generators as initial neurostimulators for deep brain stimulation in patients with movement disorders","volume":"21","author":"Jakobs","year":"2018","journal-title":"Neuromodulation"},{"issue":"4","key":"10.1016\/j.purol.2022.04.011_bib0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ner.12810","article-title":"Fixed-life or rechargeable battery for deep brain stimulation: which do patients prefer?","volume":"22","author":"Khaleeq","year":"2019","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.purol.2022.04.011_bib0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000500993","article-title":"Patient experience with rechargeable implantable pulse generator deep brain stimulation for movement disorders","volume":"97","author":"Mitchell","year":"2019","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"10.1016\/j.purol.2022.04.011_bib0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1540-8159.2005.50024.x","article-title":"Current clinical issues for MRI scanning of pacemaker and defibrillator patients","volume":"28","author":"Kalin","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.purol.2022.04.011_bib0205","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.juro.2018.05.095","article-title":"Can lumbosacral magnetic resonance imaging be performed safely in patients with a sacral neuromodulation device? An in vivo prospective study","volume":"200","author":"Guzman-Negron","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2022.04.011_bib0210","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/nau.23515","article-title":"International Continence Society best practice statement for use of sacral neuromodulation","volume":"37","author":"Goldman","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"10.1016\/j.purol.2022.04.011_bib0215","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ner.12696","article-title":"Long-term functional outcomes of S3 sacral neuromodulation for the treatment of idiopathic overactive bladder","volume":"20","author":"Ismail","year":"2017","journal-title":"Neuromodulation"},{"issue":"3","key":"10.1016\/j.purol.2022.04.011_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.purol.2020.10.006","article-title":"[Should we still offer botulinum toxin in first line treatment of idiopathic overactive bladder? Commentary to: Long-term follow-up reveals a low persistence rate of abobotulinumtoxinA injections for idiopathic overactive bladder]","volume":"31","author":"Ruffion","year":"2021","journal-title":"Prog Urol"},{"issue":"10","key":"10.1016\/j.purol.2022.04.011_bib0225","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11255-015-1100-3","article-title":"Patient preferences for treating refractory overactive bladder in the UK","volume":"47","author":"Hashim","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"10.1016\/j.purol.2022.04.011_bib0230","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00192-014-2360-7","article-title":"Women's perspective: intra-detrusor botox versus sacral neuromodulation for overactive bladder symptoms after unsuccessful anticholinergic treatment","volume":"25","author":"Balchandra","year":"2014","journal-title":"Int Urogynecol J"},{"issue":"14","key":"10.1016\/j.purol.2022.04.011_bib0235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.purol.2020.09.003","article-title":"[Follow-up and evaluation of non-neurogenic OAB treatments]","volume":"30","author":"Ph\u00e9","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2022.04.011_bib0240","series-title":"Use of patient-reported outcome and experience measures in patient care and policy","author":"KCE (Belgian Health Care Knowledge Centre)","year":"2018"},{"issue":"1","key":"10.1016\/j.purol.2022.04.011_bib0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/HJH.0000000000002592","article-title":"Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension","volume":"39","author":"Schmieder","year":"2021","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.purol.2022.04.011_bib0250","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12913-020-05373-5","article-title":"Chronic patients\u2019 satisfaction and priorities regarding medical care, information and services and quality of life: a French online patient community survey","volume":"20","author":"Ad\u00e9","year":"2020","journal-title":"BMC Health Serv Res"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:36:10Z","timestamp":1761114970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708722001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1166708722001257"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2022.04.011","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2022.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}